IBROX SUSPENSE: Tuur Rommens Transfer Hits Red Tape Despite ‘Done Deal’ Reports and Successful Medical
The Ibrox faithful have been left in a state of high-intensity anticipation as the proposed transfer of Tuur Rommens to Rangers enters a critical and unexpectedly complicated phase. While a total agreement with KVC Westerlo and a positive medical initially signaled a straightforward unveiling, the finalization of the deal has encountered a sudden administrative bottleneck that could delay the Belgian’s debut.
As of Saturday, January 10, 2026, manager Danny Röhl remains “much more positive” but cautious, as the club works frantically against the clock to register the 22-year-old in time for Sunday’s pivotal Scottish Premiership clash against Aberdeen.
The Agreement: A £7m Statement of Intent
The pursuit of Tuur Rommens is part of a broader, aggressive January strategy by Danny Röhl and Technical Director Dan Purdy. Rangers have successfully thrashed out a deal worth approximately £3.5 million (€4 million) for the Westerlo star, part of a dual-raid that also includes a £4 million move for Sturm Graz midfielder Tochi Chukwuani.
Rommens, a former Genk academy standout and a mainstay for the Belgium U21s, has been identified as the solution to Rangers’ perennial “left-back problem.” With 79 appearances over the last two years in the Jupiler Pro League, his durability and technical ceiling made the £3.5m fee—which includes a 15% sell-on clause for Westerlo—look like one of the smartest pieces of business in the division.
The Medical and the ‘Registration Logjam’
Reports from Glasgow earlier today confirmed that Rommens successfully completed his medical examination at Ross Hall. However, the expected “here we go” announcement has been stalled by administrative delays.
Sources suggest the delay stems from a combination of:
- Work Permit Formalities: Under current post-Brexit regulations, the final sign-off for European players can occasionally hit snags involving governing body endorsements.
- International Clearance: Rangers are currently waiting on the Belgian FA to release Rommens’ registration—a process that has slowed as the weekend approached.
- The ‘Double Reveal’ Strategy: Rumors within Ibrox suggest the club may be intentionally holding back the announcement to unveil both Rommens and Chukwuani together as a show of strength ahead of the Aberdeen trip.
Tactical Analysis: Why the Wait is Agonizing
Danny Röhl’s system relies heavily on high-energy full-backs who can provide width and elite delivery. Rommens is the archetypal fit for this philosophy.
With James Penrice having moved to AEK Athens and other defensive options aging, Rommens represents a tactical upgrade in speed and recovery. If the delay extends past the Sunday deadline, Röhl faces a significant tactical headache for a match that could define Rangers’ momentum in the title race.
Danny Röhl’s Verdict: A Race Against Time
Speaking to the media ahead of the weekend, a jubilant yet guarded Danny Röhl addressed the situation:
”I cannot confirm the signings yet because you never know what happens in the next 24 hours. We are in a good way, we are very positive. If they arrive, then it’s a big decision—they haven’t trained much with the group, and I have to make sure they are ready to show what they can do.”
The “big decision” Röhl refers to is whether to throw Rommens straight into the cauldron of Pittodrie. The manager’s comments suggest that even if the paperwork is cleared tonight, the lack of tactical integration remains a concern.
The Closing Window: A Test of Nerves
For the Rangers board, this delay is a unwelcome distraction in an otherwise clinical window. While there is no suggestion that the deal is in danger of collapsing, every hour that passes without a confirmed signature increases the pressure.
If the administrative hurdles are cleared by the SFA registration deadline, Rommens will be paraded as the new face of the Rangers defense. If not, the Ibrox faithful will have to wait until next week to see their new £3.5m man in blue. The next 24 hours are not just about a medical or a fee—they are about a race against the red tape.